The Multiple Sclerosis/Neuroimmunology Program at Indiana University School of Medicine provides multidisciplinary care for individuals with multiple sclerosis (MS). The Neuroimmunology/ Multiple Sclerosis Program coordinates care from neurologic, nursing, psychological, physical therapy, rehabilitation and urologic perspectives.
Clinical care incorporates the use of newer maintenance immunotherapies, including interferon-beta and glatiramer acetate as well as new symptomatic treatments, including intrathecal baclofen for spasticity and robotic therapy.
The Multiple Sclerosis Research program participates in investigational new drug studies; some trials are single-site studies at IU School of Medicine and others are part of national and international multicenter consortiums.
The Indiana University Multiple Sclerosis Center at Indiana University School of Medicine earned designation as a Partner in MS Care–Center for Comprehensive and Coordinated Care from the National Multiple Sclerosis Society.